Biofrontera
BFRIW
6 hedge funds and large institutions have $12.4K invested in Biofrontera in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
5% more capital invested
Capital invested by funds: $11.8K → $12.4K (+$550)
0.7% less ownership
Funds ownership: 2.98% → 2.28% (-0.7%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$767 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$122 |
| 2 |
CS
Clear Street
New York
|
-$53 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $11K | – | – | – |
|
|
TSS
2
Two Sigma Securities
New York
| $625 | +$767 | +10,236 | New |
|
|
CS
3
Clear Street
New York
| $569 | -$53 | -705 | -7% |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $66 | – | – | – |
|
5
US Bancorp
Minneapolis,
Minnesota
| $61 | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $54 | -$122 | -1,628 | -65% |
|
BFRIW Hedge Fund Activity: Q1 2025 in Review
6 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q1 2025, worth a combined $12.4K — up 4.7% from $11.8K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BFRIW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $767. The largest seller was UBS Group, cutting an estimated $122.
- 6 institutional investors held Biofrontera (BFRIW) as of Q1 2025, up from 5 in Q4 2024.
- Funds reported $12.4K of Biofrontera stock for Q1 2025, up 4.7% quarter-over-quarter.
- 1 fund opened new Biofrontera positions in Q1 2025 and 0 closed out, a net change of +1 holder.
- The largest Biofrontera buyer in Q1 2025 was Two Sigma Securities, an estimated $767 added.
- The largest Biofrontera seller in Q1 2025 was UBS Group, an estimated $122 sold.
Based on aggregated 13F filings for Q1 2025.